Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early ACE inhibitor and beta-blocker intervention for subclinical cardiomyopathy prevention in Duchenne muscular dystrophy
ChiCTR2000032525Phase 4Recruiting
- Sponsor
- West China Second University Hospital
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of perindopril and metoprolol in Duchenne muscular dystrophy (DMD) (3 arms), sponsored by West China Second University Hospital. Primary endpoints: Medical Research Council Scale, Three functional tasks and 5 more. Started May 2020; status: recruiting.
02
Drugs
perindoprilmetoprolol
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on ChiCTR2000032525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032525.